Inhaled Corticosteroids for the Prevention of Bronchopulmonary Dysplasia and Complications of Prematurity

Affiliations

Comment

Gerardo A Vazquez-Garcia et al. Am J Respir Crit Care Med. 2019.

. 2019 Jul 1;200(1):98-100.

doi: 10.1164/rccm.201808-1469RR.

¹ Children's Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania.

No abstract available

Comment on

Inhaled hydrofluoalkane-beclomethasone dipropionate in bronchopulmonary dysplasia. A double-blind, randomized, controlled pilot study.
Kugelman A, Peniakov M, Zangen S, Shiff Y, Riskin A, Iofe A, Shoris I, Bader D, Arnon S. Kugelman A, et al. J Perinatol. 2017 Feb;37(2):197-202. doi: 10.1038/jp.2016.177. Epub 2016 Oct 13. J Perinatol. 2017. PMID: 27735931 Clinical Trial.
Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia.
Bassler D, Shinwell ES, Hallman M, Jarreau PH, Plavka R, Carnielli V, Meisner C, Engel C, Koch A, Kreutzer K, van den Anker JN, Schwab M, Halliday HL, Poets CF; Neonatal European Study of Inhaled Steroids Trial Group. Bassler D, et al. N Engl J Med. 2018 Jan 11;378(2):148-157. doi: 10.1056/NEJMoa1708831. N Engl J Med. 2018. PMID: 29320647 Clinical Trial.
Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study.
Raghuram K, Dunn M, Jangaard K, Reilly M, Asztalos E, Kelly E, Vincer M, Shah V. Raghuram K, et al. BMC Pediatr. 2018 May 7;18(1):153. doi: 10.1186/s12887-018-1134-7. BMC Pediatr. 2018. PMID: 29734948 Free PMC article.